A Study to Establish a New Onset Hyperglycemia and Diabetes Cohort
Public ClinicalTrials.gov record NCT03731637. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective Study to Establish a New Onset Hyperglycemia and Diabetes (NOD) Cohort
Study identification
- NCT ID
- NCT03731637
- Recruitment status
- Terminated
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Fred Hutchinson Cancer Center
- Other
- Enrollment
- 2,269 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 50 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 14, 2018
- Primary completion
- Mar 30, 2025
- Completion
- Mar 30, 2025
- Last update posted
- Apr 29, 2025
2018 – 2025
United States locations
- U.S. sites
- 18
- U.S. states
- 12
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Kaiser Permanente Southern California | Los Angeles | California | 90027 | — |
| Cedars Sinai Medical Center | Los Angeles | California | 90048 | — |
| Greater Los Angeles Veterans Affairs Medical Center | Los Angeles | California | 90073 | — |
| Kaiser Permanente Northern California | Oakland | California | 94612 | — |
| Stanford University Medical Center | Palo Alto | California | 94605 | — |
| University of Florida | Gainesville | Florida | 32608 | — |
| Advent Health Translational Research Institute | Orlando | Florida | 32804 | — |
| Carle Foundation Hospital | Urbana | Illinois | 61801 | — |
| Univeristy Hospital, Indiana University Health | Indianapolis | Indiana | 46202 | — |
| Ochsner Medical Center | New Orleans | Louisiana | 70121 | — |
| Henry Ford Health System | Detroit | Michigan | 48202 | — |
| Trinity Health Ann Arbor Hospital | Ypsilanti | Michigan | 48197 | — |
| Mayo Clinic | Rochester | Minnesota | 55905 | — |
| The Ohio State University Wexner Medical Center | Columbus | Ohio | 43210 | — |
| University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | 15213 | — |
| Gibbs Cancer Center & Research Institute | Spartanburg | South Carolina | 29303 | — |
| Baylor College of Medicine | Houston | Texas | 77030 | — |
| Marshfield Clinic Health System | Marshfield | Wisconsin | 54449 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03731637, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 29, 2025 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03731637 live on ClinicalTrials.gov.